Research output per year
Research output per year
- 1 - 50 out of 2,225 results
Search results
-
2024
Acute esophageal stricture after bone marrow transplant
Pang, S., Saleh, H., Ailawadhi, S., Edgar, M. & Pang, M., Feb 2024, In: Clinical Journal of Gastroenterology. 17, 1, p. 1-5 5 p.Research output: Contribution to journal › Article › peer-review
-
An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
Alodhaibi, I., Ailawadhi, S., Burbano, G. P., O'Brien, P. J., Buadi, F. K., Hayman, S., Kumar, S. K. & Gonsalves, W. I., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article › peer-review
-
A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis
Southern, B. D., Li, H., Mao, H., Crish, J. F., Grove, L. M., Scheraga, R. G., Mansoor, S., Reinhardt, A., Abraham, S., Deshpande, G., Loui, A., Ivanov, A. I., Rosenfeld, S. S., Bresnick, A. R. & Olman, M. A., Jan 2024, In: Journal of Biological Chemistry. 300, 1, 105530.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
Beckermann, K. E., Patnaik, A., Winer, I., Tan, W., Bashir, B., Kyriakopoulos, C. E., Sweis, R. F., Chamberlain, M. & Rini, B. I., Apr 2024, In: Investigational New Drugs. 42, 2, p. 179-184 6 p.Research output: Contribution to journal › Article › peer-review
-
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia
Parrondo, R. D., Dutta, N., LaPlant, B. R., Elliott, J., Fernandez, A., Zimmerman, A., Cicco, G., Han, B., Heslop, K., Chapin, D., Sher, T., Roy, V., Rasheed, A., Das, S., Chanan-Khan, A. A., Paulus, A. & Ailawadhi, S., 2024, (Accepted/In press) In: British journal of haematology.Research output: Contribution to journal › Article › peer-review
-
A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients
Ames, S. C., Lange, L., Ames, G. E., Heckman, M. G., White, L. J., Roy, V. & Foran, J. M., Feb 2024, In: Cancer medicine. 13, 3, e6906.Research output: Contribution to journal › Article › peer-review
Open Access -
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis
Mosalem, O., Tan, W., Bryce, A. H., Dronca, R. S., Childs, D. S., Pagliaro, L. C., Orme, J. J. & Kase, A. M., 2024, (Accepted/In press) In: Prostate Cancer and Prostatic Diseases.Research output: Contribution to journal › Article › peer-review
Open Access -
Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA
Ailawadhi, S., Ravelo, A., Ng, C. D., Shah, B., Lamarre, N., Wang, R., Eakle, K. & Biondo, J. M., Feb 1 2024, In: Journal of Comparative Effectiveness Research. 13, 2, p. e230119Research output: Contribution to journal › Review article › peer-review
Open Access -
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
Cai, S. F., Huang, Y., Lance, J. R., Mao, H. C., Dunbar, A. J., McNulty, S. N., Druley, T., Li, Y., Baer, M. R., Stock, W., Kovacsovics, T., Blum, W. G., Schiller, G. J., Olin, R. L., Foran, J. M., Litzow, M., Lin, T., Patel, P., Foster, M. C., Boyiadzis, M., & 18 others, Jan 23 2024, In: Blood Advances. 8, 2, p. 429-440 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Awake Craniotomy Program Implementation
Moniz-Garcia, D., Bojaxhi, E., Borah, B. J., Dholakia, R., Kim, H., Sousa-Pinto, B., Almeida, J. P., Mendhi, M., Freeman, W. D., Sherman, W., Christel, L., Rosenfeld, S., Grewal, S. S., Middlebrooks, E. H., Sabsevitz, D., Gruenbaum, B. F., Chaichana, K. L. & Quiñones-Hinojosa, A., Jan 24 2024, In: JAMA Network Open. 7, 1, p. E2352917Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy
Li, S., Manochakian, R., Chen, R., Patel, J., Inampudi, J. V., Hiren, K. R., Zhao, Y. & Lou, Y., 2024, In: Frontiers in Oncology. 14, 1306311.Research output: Contribution to journal › Article › peer-review
Open Access -
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma
Alhaj Moustafa, M., Parrondo, R., Abdulazeez, M. F., Roy, V., Sher, T., Alegria, V. R., Warsame, R. M., Fonseca, R., Rasheed, A., Gonsalves, W. I., Kourelis, T., Kapoor, P., Buadi, F. K., Dingli, D., Hayman, S. R., Reeder, C. B., Chanan-Khan, A. A. & Ailawadhi, S., Jan 1 2024, In: Anti-cancer drugs. 35, 1, p. 63-69 7 p.Research output: Contribution to journal › Article › peer-review
-
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition
Barzi, A., Weipert, C. M., Espenschied, C. R., Raymond, V. M., Wang-Gillam, A., Nezami, M. A., Gordon, E. J., Mahadevan, D. & Mody, K., 2024, In: Frontiers in Oncology. 14, 1339302.Research output: Contribution to journal › Article › peer-review
Open Access -
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
HIMALAYA investigators, 2024, (Accepted/In press) In: Annals of Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
From the Operating Room to the Laboratory: Role of the Neuroscience Tissue Biorepository in the Clinical, Translational, and Basic Science Research Pipeline
Quiñones-Hinojosa, A., Basil, A., Moniz-Garcia, D., Suarez-Meade, P., Ramos, A., Jentoft, M., Middlebrooks, E., Grewal, S., Abode-Iyamah, K., Bydon, M., Sarkaria, J., Dickson, D., Swanson, K., Rosenfeld, S., Schiapparelli, P., Guerrero-Cazares, H., Chaichana, K. & Meyer, F., Feb 2024, In: Mayo Clinic proceedings. 99, 2, p. 229-240 12 p.Research output: Contribution to journal › Article › peer-review
-
Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms
Baranwal, A., Basmaci, R., He, R., Viswanatha, D., Greipp, P., Murthy, H. S., Foran, J., Palmer, J., Hogan, W., Litzow, M. R., Hefazi, M., Mangaonkar, A., Shah, M. V., Al-Kali, A. & Alkhateeb, H. B., Feb 13 2024, In: Blood Advances. 8, 3, p. 562-570 9 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
Delforge, M., Patel, K., Eliason, L., Dhanda, D., Shi, L., Guo, S., Marshall, T. S., Arnulf, B., Cavo, M., Nooka, A., Manier, S., Callander, N., Giralt, S., Einsele, H., Ailawadhi, S., Popa McKiver, M., Cook, M. & Rodríguez-Otero, P., Mar 2024, In: The Lancet Haematology. 11, 3, p. e216-e227Research output: Contribution to journal › Article › peer-review
-
Implementation of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education
Vern-Gross, T. Z., Laughlin, B. S., Kough, K., Ernst, B., Langley, N., Rule, W. G., Patel, S. H. & Ashman, J. B., Feb 1 2024, In: Journal of Palliative Medicine. 27, 2, p. 231-235 5 p.Research output: Contribution to journal › Article › peer-review
-
Loneliness, immunological recovery patterns, and health-related quality of life (HRQOL) outcomes in patients receiving hematopoietic stem cell transplantation
Lange, L. J., Ames, S. C., Ames, G. E., Heckman, M. G., White, L. J., Roy, V. & Foran, J. M., Dec 2024, In: BMC psychology. 12, 1, 40.Research output: Contribution to journal › Article › peer-review
Open Access -
Lung Injury Prediction Model in Bone Marrow Transplantation: A Multicenter Cohort Study
Herasevich, S., Schulte, P., Hogan, W., Alkhateeb, H., Zhang, Z., White, B. A., Khera, N., Roy, V., Gajic, O. & Yadav, H., Mar 1 2024, In: American journal of respiratory and critical care medicine. 209, 5, p. 543-552 10 p.Research output: Contribution to journal › Article › peer-review
-
Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma
Nadeem, O., Ailawadhi, S., Khouri, J., Williams, L., Catamero, D., Maples, K. & Berdeja, J., Mar 2024, In: Cancers. 16, 5, 1023.Research output: Contribution to journal › Review article › peer-review
Open Access -
Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia
Gangat, N., McCullough, K., Abdelmagid, M., Karrar, O., Powell, M., Al-Kali, A., Alkhateeb, H., Begna, K., Mangaonkar, A., Saliba, A., Torghabeh, M. H., Litzow, M., Hogan, W., Shah, M., Patnaik, M., Pardanani, A., Badar, T., Foran, J., Palmer, J., Sproat, L., & 2 others, Jan 2024, In: Haematologica. 109, 1, p. 287-292 6 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Hieken, T. J., Nelson, G. D., Flotte, T. J., Grewal, E. P., Chen, J., McWilliams, R. R., Kottschade, L. A., Yang, L., Domingo-Musibay, E., Dronca, R. S., Yan, Y., Markovic, S. N., Dimou, A., Montane, H. N., Erskine, C. L., Piltin, M. A., Price, D. L., Khariwala, S. S., Hui, J., Strand, C. A., & 4 others, Dec 2024, In: Nature communications. 15, 1, 1430.Research output: Contribution to journal › Article › peer-review
Open Access -
Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable
Ailawadhi, S., Shune, L., Wong, S. W., Lin, Y., Patel, K. & Jagannath, S., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Short survey › peer-review
Open Access -
Pharmacokinetics of dacarbazine and unesbulin and CYP1A2-mediated drug interactions in patients with leiomyosarcoma
Gao, L., Kaushik, D., Van Tine, B. A., Ingham, M. A., Attia, S., Meyer, C. F., Schwartz, G. K., Maliakal, P., Baird, J. D., Ma, J., Barrett, R., D'Silva, D., O'Keefe, K. & Kong, R., Feb 2024, In: Clinical and translational science. 17, 2, e13709.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up
Abdallah, N., Witzig, T. E., Kumar, S. K., Lacy, M. Q., Hayman, S. R., Dispenzieri, A., Roy, V., Gertz, M. A., Bergsagel, P. L. & Rajkumar, S. V., 2024, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Letter › peer-review
-
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry
Ballas, L., Ailawadhi, S., Narang, M., Gasparetto, C. J., Lee, H. C., Hardin, J. W., Durie, B. G. M., Toomey, K., Omel, J., Wagner, L. I., Abonour, R., Terebelo, H. R., Joshi, P., Yu, E., Liu, L., Rifkin, R. M. & Jagannath, S., Mar 1 2024, In: Practical Radiation Oncology. 14, 2, p. e141-e149Research output: Contribution to journal › Article › peer-review
-
Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma
Quach, H., Parmar, G., Mateos, M. V., Ailawadhi, S. & Leleu, X., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Review article › peer-review
-
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial
Heinrich, M. C., Jones, R. L., George, S., Gelderblom, H., Schöffski, P., von Mehren, M., Zalcberg, J. R., Kang, Y. K., Razak, A. A., Trent, J., Attia, S., Le Cesne, A., Siontis, B. L., Goldstein, D., Boye, K., Sanchez, C., Steeghs, N., Rutkowski, P., Druta, M., Serrano, C., & 9 others, Feb 2024, In: Nature Medicine. 30, 2, p. 498-506 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Serum hormone concentrations and individualisation of breast cancer prevention
Chumsri, S., Jan 2024, In: The Lancet Oncology. 25, 1, p. 8-9 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Superior detection rate of plasma cell FISH using FACS-FISH
Gagnon, M. F., Midthun, S. M., Fangel, J. A., Schuh, C. M., Luoma, I. M., Pearce, K. E., Meyer, R. G., Ailawadhi, S., Arribas, M. J., Braggio, E., Fonseca, R., Rajkumar, S. V., Zepeda-Mendoza, C., Xu, X., Greipp, P. T., Timm, M. M., Otteson, G. E., Shi, M., Jevremovic, D., Olteanu, H., & 4 others, Jan 1 2024, In: American journal of clinical pathology. 161, 1, p. 60-70 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study
Martins-Branco, D., Kassapian, M., Debien, V., Caparica, R., Eiger, D., Dafni, U., Andriakopoulou, C., El-Abed, S., Ellard, S. L., Izquierdo, M., Vicente, M., Chumsri, S., Piccart-Gebhart, M., Moreno-Aspitia, A., Knop, A. S., Lombard, J. & de Azambuja, E., Feb 2024, In: Breast Cancer Research and Treatment. 203, 3, p. 497-509 13 p.Research output: Contribution to journal › Article › peer-review
-
The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer
Sacchi de Camargo Correia, G., Zhao, Y., Manochakian, R. & Lou, Y., 2024, In: Frontiers in Oncology. 14, 1336546.Research output: Contribution to journal › Review article › peer-review
Open Access -
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations
Pemmaraju, N., Madanat, Y. F., Rizzieri, D., Fazal, S., Rampal, R., Mannis, G., Wang, E. S., Foran, J. & Lane, A. A., 2024, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Review article › peer-review
Open Access -
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
Gangat, N., Karrar, O., Iftikhar, M., McCullough, K., Johnson, I. M., Abdelmagid, M., Abdallah, M., Al-Kali, A., Alkhateeb, H. B., Begna, K. H., Mangaonkar, A., Saliba, A. N., Hefazi Torghabeh, M., Litzow, M. R., Hogan, W., Shah, M., Patnaik, M. M., Pardanani, A., Badar, T., Murthy, H., & 6 others, Feb 2024, In: American journal of hematology. 99, 2, p. 193-202 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival
Karrar, O., Abdelmagid, M., Rana, M., Iftikhar, M., McCullough, K., Al-Kali, A., Alkhateeb, H. B., Begna, K. H., Elliott, M. A., Mangaonkar, A., Saliba, A., Hefazi Torghabeh, M., Litzow, M. R., Hogan, W., Shah, M., Patnaik, M. M., Pardanani, A., Badar, T., Murthy, H., Foran, J., & 6 others, Feb 2024, In: American journal of hematology. 99, 2, p. E63-E66Research output: Contribution to journal › Letter › peer-review
Open Access -
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients
Nanaa, A., He, R., Foran, J. M., Badar, T., Gangat, N., Pardanani, A., Hogan, W. J., Litzow, M. R., Patnaik, M., Al-Kali, A. & Alkhateeb, H. B., Jan 2024, In: British journal of haematology. 204, 1, p. 171-176 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Abdallah, M., McCullough, K., Ilyas, R., Begna, K. H., Al-Kali, A., Litzow, M. R., Hogan, W. J., Mangaonkar, A., Alkhateeb, H., Shah, M. V., Elliott, M. A., Foran, J. M., Badar, T., Palmer, J. M., Yi, C. A., Sproat, L., Pardanani, A., Patnaik, M. M., Olteanu, H., Ketterling, R. P., & 2 others, Dec 2023, In: Blood cancer journal. 13, 1, 35.Research output: Contribution to journal › Letter › peer-review
Open Access -
Abscopal Effect Following Cryoablation in a Patient with Metastatic Breast Cancer
Kaplan, J. L., Turker, I., Chumsri, S. & Gabriel, E., Mar 2023, In: Frontiers in Bioscience - Scholar. 15, 1, fbs1501002.Research output: Contribution to journal › Article › peer-review
Open Access -
A Calcineurin Inhibitor Free Graft Versus Host Disease Prophylaxis for Patients Undergoing Matched Related and Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplant
Iqbal, M., Nieto, F. A. M., Brannick, K. M., Li, Z., Murthy, H., Foran, J., Roy, V., Kharfan-Dabaja, M. A. & Ayala, E., May 2023, In: Transplantation and Cellular Therapy. 29, 5, p. 327.e1-327.e9Research output: Contribution to journal › Article › peer-review
-
A case report of 2 distinct primary sarcomas arising in an extremity in rapid succession
Isaza, L. F., Garner, H. W., Edgar, M. A., Attia, S. & Wilke, B. K., Jan 2023, In: Radiology Case Reports. 18, 1, p. 70-74 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis
Wolf, E. B., Li, D., Fernandez, A. J., Gardner, L. B., Rivera, C. E., Wysokinska, E. M., Shaikh, M. E., Tun, H. W., Roy, V. & Alhaj Moustafa, M., Jan 1 2023, In: Journal of Investigative Medicine High Impact Case Reports. 11Research output: Contribution to journal › Article › peer-review
Open Access -
Acute Myeloid Leukemia, Version 3.2023
Pollyea, D. A., Altman, J. K., Assi, R., Bixby, D., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jonas, B. A., Kishtagari, A., Lancet, J., Maness, L., Mangan, J., Mannis, G., Marcucci, G., Mims, A., Moriarty, K., Ali, M. M., Neff, J., Nejati, R., & 17 others, May 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 5, p. 503-513 11 p.Research output: Contribution to journal › Article › peer-review
-
Advancing outcomes of metastatic HER2-positive breast cancer
Chumsri, S., May 27 2023, In: The Lancet. 401, 10390, p. 1746-1747 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety
Das, S., Ailawadhi, S., Sher, T., Roy, V., Fernandez, A. & Parrondo, R. D., Nov 2023, In: Current Oncology. 30, 11, p. 9627-9633 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)
Visram, A., Hayman, S. R., Dispenzieri, A., Kapoor, P., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Dingli, D., Warsame, R., Kourelis, T., Cook, J., Binder, M., Gonsalves, W., Muchtar, E., Leung, N., Roy, V., Rajkumar, S. V. & Kumar, S., Aug 2023, In: American journal of hematology. 98, 8, p. 1277-1285 9 p.Research output: Contribution to journal › Article › peer-review
-
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
Attia, S., Bolejack, V., Ganjoo, K. N., George, S., Agulnik, M., Rushing, D., Loggers, E. T., Livingston, M. B., Wright, J., Chawla, S. P., Okuno, S. H., Reinke, D. K., Riedel, R. F., Davis, L. E., Ryan, C. W. & Maki, R. G., Jan 2023, In: Cancer medicine. 12, 2, p. 1532-1539 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
Smith, K. E. R., Peng, K. W., Pulido, J. S., Weisbrod, A. J., Strand, C. A., Allred, J. B., Newsom, A. N., Zhang, L., Packiriswamy, N., Kottke, T., Tonne, J. M., Moore, M., Montane, H. N., Kottschade, L. A., McWilliams, R. R., Dudek, A. Z., Yan, Y., Dimou, A., Markovic, S. N., Federspiel, M. J., & 3 others, 2023, In: Frontiers in immunology. 14, 1279387.Research output: Contribution to journal › Article › peer-review
Open Access -
ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer
Huang, K., Jakub, J., Gabriel, E., Moreno-Aspitia, A. & McLaughlin, S., Nov 1 2023, In: Annals of surgical oncology. 30, 12, p. 7143 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
Ailawadhi, S., Parrondo, R. D., Dutta, N., Han, B., Ciccio, G., Cherukuri, Y., Alegria, V. R., LaPlant, B. R., Roy, V., Sher, T., Edwards, B., Lanier, S., Manna, A., Heslop, K., Caulfield, T., Maldosevic, E., Storz, P., Manochakian, R., Asmann, Y., Chanan-Khan, A. A., & 1 others, Jan 2023, In: Cancers. 15, 2, 477.Research output: Contribution to journal › Article › peer-review
Open Access